Image de couverture de livre

Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the 17 and 29 Alleles

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Matthew H. Bennett, Ethan A. Poweleit, Samuel E. Vaughn, Brandon Retke, Paul Toren, Jeffrey R. Strawn, Laura B. Ramsey
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	Clinical and Translational Science
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin
par: Rubin Lubomirov, et autres
Publié: (2025)

Association of Metabolic Genotype Composite CYP3A5*3 and CYP3A4*1B to Tacrolimus Pharmacokinetics in Stable Black and White Kidney Transplant Recipients
par: Daniel Brazeau, et autres
Publié: (2025)

Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents
par: Ethan A. Poweleit, et autres
Publié: (2024)

Influence of novel CYP2C‐haplotype on proton pump inhibitor pharmacokinetics in children
par: Kathryn E. Kyler, et autres
Publié: (2024)

CYP2C19 Genotype‐Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure
par: Kayla R. Tunehag, et autres
Publié: (2025)

Impact of CYP2D6 Metabolizer Status on Ondansetron Efficacy in Early Pregnancy Induced Nausea and Vomiting: A Case Control Study
par: Michelle Liu, et autres
Publié: (2026)

Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain
par: Ana Casajús, et autres
Publié: (2024)

Recipient Versus Donor CYP3A4/5 Genotypes in Adult Liver Transplant Recipients to Achieve Therapeutic Tacrolimus Concentrations Early Post‐Transplant
par: Eda Eken, et autres
Publié: (2025)

A Modeling Investigation of the CYP1A Drug Interactions of Riluzole
par: Paul Malik, et autres
Publié: (2025)

Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study
par: Rachel Conyers, et autres
Publié: (2025)

Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants
par: Jason D. Kim, et autres
Publié: (2026)

Evaluation of Drug–Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants
par: Alison Luckey, et autres
Publié: (2026)

Pharmacogenetic hSLCO1B1*14 ‐Guided Dosing of Methotrexate in Transgenic Arthritic Mice Normalizes Exposure and Response
par: Felicia Gooden, et autres
Publié: (2025)

Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
par: Sylvia D. Klomp, et autres
Publié: (2024)

Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
par: Jumar Etkins, et autres
Publié: (2025)

Sodium‐Glucose Cotransporter 2 Inhibitors Use and Adverse Kidney Outcomes in Patients Receiving Contrast Media
par: Lung‐Chih Li, et autres
Publié: (2025)

Correction to “Genotype‐Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers”
Publié: (2026)

Inter‐Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials
par: Nicki M. Kyriacou, et autres
Publié: (2025)

A Multicenter Randomized Controlled Study on Pharmacokinetic‐Guided Vancomycin Use in Children With Severe Infections
par: Fuxiang He, et autres
Publié: (2025)

Association of CYP2C19 genotypes with postoperative atrial fibrillation after coronary artery bypass surgery
par: Qin Jiang, et autres
Publié: (2024)

Interindividual variability in CYP3A‐mediated venetoclax metabolism in vitro and in vivo in patients with chronic lymphocytic leukemia
par: Jonghwa Lee, et autres
Publié: (2024)

CYP2C19 Polymorphism and Platelet Aggregation‐Associated Risks in Atrial Fibrillation Patients Undergoing PCI
par: Diona Gjermeni, et autres
Publié: (2026)

In vitro comparative analysis of metabolic capabilities and inhibitory profiles of selected CYP2D6 alleles on tramadol metabolism
par: Noor Ahmed Nahid, et autres
Publié: (2025)

Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies
par: Leonela Luce, et autres
Publié: (2026)

Running Shoe Recommendations Based on Gait Analysis Improve Perceptions of Comfort, Performance and Injury Risk: A Single‐Blind Randomised Crossover Trial
par: Andrew Fife, et autres
Publié: (2025)

APOE Genotype and Statin Response: Evidence From the UK Biobank and All of Us Program
par: Innocent G. Asiimwe, et autres
Publié: (2025)

Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans
par: Sungyeun Bae, et autres
Publié: (2026)

Physiologically Based Pharmacokinetic Modeling of Valemetostat to Inform Dose Recommendations When Coadministered With CYP3A /P‐gp Modulators
par: Akiko Watanabe, et autres
Publié: (2025)

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients
par: Qinglian Zhai, et autres
Publié: (2024)

Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers
par: Hengbang Wang, et autres
Publié: (2024)

Commentary on “The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type”
par: Majid Khalilizad, et autres
Publié: (2025)

Amyloid‐Related Imaging Abnormality (ARIA) Beyond the APOE‐ε4 Allele
par: Valentinus Besin, et autres
Publié: (2025)

Risk and Association of Specific HLA Alleles With Nintedanib‐Induced Gastrointestinal Adverse Reactions: A Discovery Study in an Italian Population
par: Stefano Mocci, et autres
Publié: (2025)

Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation
par: Jie Huang, et autres
Publié: (2024)

Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers
par: Flora Tassone, et autres
Publié: (2026)

The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first‐in‐class ACKR3/CXCR7 antagonist, ACT‐1004‐1239
par: Christine Huynh, et autres
Publié: (2024)

Impact of Efavirenz on Heme Protein Induction and Biomarkers: Insights From In Vitro Experiments and a Clinical Study
par: Leila Potzel, et autres
Publié: (2026)

Effect of Selective Serotonin Reuptake Inhibitors on Coagulation: Fact or Fiction?
par: Antoine Mokhtarian, et autres
Publié: (2025)

Translation norms in the light of practical research in literary translation
par: Mercedes Enríquez-Aranda
Publié: (2016)

Real‐World Characterization of Psychiatric Pharmacogenomic Test Ordering and Clinical Relevance in Adults and Children
par: Lusi Zhang, et autres
Publié: (2025)